Literature DB >> 19555828

Huntington disease and other choreas.

Francisco Cardoso1.   

Abstract

Chorea is defined as a syndrome characterized by brief, abrupt involuntary movements resulting from a continuous flow of random muscle contractions. There are genetic and non-genetic causes of chorea. The most common genetic cause of chorea is Huntington's disease (HD). Non-genetic forms of chorea include vascular choreas, auto-immune choreas, metabolic and toxic choreas, and drug-induced choreas. This chapter provides an overview of clinical features, pathogenesis and management of HD, other important genetic causes of chorea, Sydenham's chorea, other autoimmune choreas and vascular choreas.

Entities:  

Mesh:

Year:  2009        PMID: 19555828     DOI: 10.1016/j.ncl.2009.04.001

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  12 in total

1.  Hemichorea in a thymoma patient without anti-CRMP-5 antibody.

Authors:  Yoshiharu Nakae; Shingo Ikeda; Ryoo Yamamoto; Fumiaki Tanaka; Ken Johkura
Journal:  Neurol Sci       Date:  2014-01-11       Impact factor: 3.307

2.  Feasibility and initial validation of 'HD-Mobile', a smartphone application for remote self-administration of performance-based cognitive measures in Huntington's disease.

Authors:  Brendan McLaren; Sophie C Andrews; Yifat Glikmann-Johnston; Emily-Clare Mercieca; Nicholas W G Murray; Clement Loy; Mark A Bellgrove; Julie C Stout
Journal:  J Neurol       Date:  2020-09-03       Impact factor: 4.849

3.  Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington's disease.

Authors:  Kathleen J Griffioen; Ruiqian Wan; Tashalee R Brown; Eitan Okun; Simonetta Camandola; Mohamed R Mughal; Terry M Phillips; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2011-12-31       Impact factor: 4.673

4.  deutetrabenazine for the treatment of chorea associated with Huntington's disease.

Authors:  Harshit Gupta; Wil Perkins; Cain Stark; Sathya Kikkeri; Juyeon Kakazu; Adam Kaye; Alan Kaye
Journal:  Health Psychol Res       Date:  2022-06-28

5.  Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.

Authors:  Jean Lud Cadet; Christie Brannock; Irina N Krasnova; Bruce Ladenheim; Michael T McCoy; Jenny Chou; Elin Lehrmann; William H Wood; Kevin G Becker; Yun Wang
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

6.  Treatment of Essential Tremor: Are there Issues We are Overlooking?

Authors:  Elan D Louis
Journal:  Front Neurol       Date:  2012-01-13       Impact factor: 4.003

7.  CD4⁺ but not CD8⁺ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice.

Authors:  L Rattazzi; G Piras; M Ono; R Deacon; C M Pariante; F D'Acquisto
Journal:  Transl Psychiatry       Date:  2013-07-09       Impact factor: 6.222

Review 8.  Revisiting the neuropsychiatry of Huntington's disease.

Authors:  Antonio Lucio Teixeira; Leonardo Cruz de Souza; Natalia Pessoa Rocha; Erin Furr-Stimming; Edward C Lauterbach
Journal:  Dement Neuropsychol       Date:  2016 Oct-Dec

9.  Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington's disease mice.

Authors:  Kathleen Griffioen; Mark P Mattson; Eitan Okun
Journal:  Heliyon       Date:  2018-01-18

Review 10.  Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies.

Authors:  Natalia P Rocha; Fabiola M Ribeiro; Erin Furr-Stimming; Antonio L Teixeira
Journal:  Mediators Inflamm       Date:  2016-08-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.